Date: Feb 06, 2020 Source: pharmamedtechbi.com (
click here to go to the source)
Executive Summary
Cardiovascular device company Abiomed will acquire BeneCor Heart Systems, a year-old company developing replacement hearts, with 55k of its common shares. Based on Abiomed's average trading price, the deal is worth about $3.1mm.